Evaluation of radiation safety of the newly established national New Zealand 177–Lutetium (177-Lu or Lutate) Peptide Receptor Radiation Therapy (PRRT) service, a palliative treatment for patients with metastatic neuroendocrine tumours.
In: Journal of Medical Imaging & Radiation Sciences, Jg. 53 (2022-06-02), S. S22- (9S.)
academicJournal
Zugriff:
Titel: |
Evaluation of radiation safety of the newly established national New Zealand 177–Lutetium (177-Lu or Lutate) Peptide Receptor Radiation Therapy (PRRT) service, a palliative treatment for patients with metastatic neuroendocrine tumours.
|
---|---|
Autor/in / Beteiligte Person: | Davidson, Jennifer ; Hull, Avril ; Mead, Trish ; Lunt, Brian ; Stewart, Allan |
Zeitschrift: | Journal of Medical Imaging & Radiation Sciences, Jg. 53 (2022-06-02), S. S22- (9S.) |
Veröffentlichung: | 2022 |
Medientyp: | academicJournal |
ISSN: | 1939-8654 (print) |
DOI: | 10.1016/j.jmir.2022.03.010 |
Schlagwort: |
|
Sonstiges: |
|